Intellectual Property India Publishes Patent Application for 'Fgf21 Mutant Polypeptides' Filed by Akero Therapeutics, Inc.

MUMBAI, India, May 2 -- Intellectual Property India has published a patent application (202517028164 A) filed by Akero Therapeutics, Inc., San Francisco, on March 25, for 'fgf21 mutant polypeptides.'

Inventor(s) include Rolph, Timothy, P.; and Tillman, Erik, J.

The application for the patent was published on May 2, under issue no. 18/2025.

According to the abstract released by the Intellectual Property India: "The disclosure provides a complex comprising (a) a first monomer comprising an Fc domain fused to two FGF21 domains comprising the amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 4, which may be the same or different, and (b) a second monomer comprising an Fc domain fused to at least one FGF21 domain comprising the amino acid seq...